Singapore: Viralytics reported strong interim results from its phase II clinical trial of Cavatak treatment in late stag...
Singapore: The global pre-diabetes population is three times the size of the current diabetes patient population and the...
Singapore: Genzyme, a Sanofi company, received approval from the US FDA for AUBAGIO (teriflunomide) as a new once-daily,...
Singapore: Taiwan's TaiGen Biotechnology has submitted New Drug Application (NDA) for the oral formulation of nemonoxaci...
Singapore: Illumina announced that Teva Pharmaceutical has signed an exclusive agreement with Verinata Health, an Illumi...
Singapore: Global biopharmaceutical firm Merck Serono has initiated international Phase III trial of its investigational...
Singapore: Boehringer Ingelheim has recieved Euroean approval for Pradaxa (dabigatran etexilate) for the treatment and p...
Singapore: AstraZeneca has formed collaboration with Korea's LegoChem Biosciences to develop a novel antibiotic to treat...
Singapore: Drug resistance and patent expiries are demanding that the antibacterial drug market moves forward soon, but ...
Singapore: Cancer Therapeutics, an Australian company focused on translating cancer biology research into novel treatmen...
Singapore: The WHO has prequalified Eisai's drug NTD002, a 100 mg tablet of diethylcarbamazine (DEC) for treatment of el...
Singapore: Bayer's Stivarga (regorafenib) became the second drug to have been approved in the past two months by the US ...
Singapore: CSL has developed a new drug candidate that is able to prevent the development of type 2 diabetes and revers...
Singapore: Novartis oncology president, Mr Hervé Hoppenot, has stepped down from the position to pursue a career oppo...
Singapore: Hodgkin lymphoma survivors, who received certain radiation and chemotherapy regimens, were at increased risk ...
Singapore: A study by Janssen Research and Development revealed that patients with active psoriatic arthritis, who were ...
Singapore: Swiss chemicals and drug company Lonza and USA-based BioWa, a wholly-owned subsidiary of Japan's Kyowa Hakko ...
Singapore: A joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committ...
